GLUT1 as a Potential Therapeutic Target in Glioblastoma
Brain Sciences · 28.05.2025 · 15 (6) · 585
DOI: 10.3390/brainsci15060585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 28.05.2025. Verfasst von Fnu Ruchika und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma (GBM) is the most common primary brain tumor in adults, with a median survival of 15–18 months. GBM cells, like all tumors, exhibit a metabolic shift known as the Warburg effect, favoring glycolysis even under normoxic conditions. GLUT1 is a primary glucose transporter in GBM cells and has been found to be overexpressed in these cells. The acidic microenvironment created by glycolysis facilitates immune evasion, therapy resistance, and tumor growth. Overexpression of GLUT1 is driven by hypoxia-inducible factor-1α (HIF-1α), c-Myc, and other pathways which have been correlated with tumor aggressiveness as well as poor prognosis Recent studies have highlighted the therapeutic potential of targeting GLUT1 in GBM. Preclinical research shows that GLUT1 inhibitors, such as WZB117 and BAY-876, effectively impair tumor metabolism, reduce cell viability, and improve survival in vitro and in animal models. GLUT1 expression also serves as a prognostic marker, with elevated levels linked to poor outcomes. This review highlights the importance of GLUT1 in GBM biology as a potential therapeutic target and biomarker.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.
ORCID-Profile: Fnu Ruchika, Sanika Suvarnapathaki, Jordina Rincon-Torroella
Zitieren
APA
Ruchika, F., Suvarnapathaki, S., Serrano-Farias, A., Bettegowda, C., & Rincon-Torroella, J. (2025). GLUT1 as a Potential Therapeutic Target in Glioblastoma. Brain Sciences, 15(6), 585. https://doi.org/10.3390/brainsci15060585
Vancouver
Ruchika F, Suvarnapathaki S, Serrano-Farias A, Bettegowda C, Rincon-Torroella J. GLUT1 as a Potential Therapeutic Target in Glioblastoma. Brain Sciences. 2025;15(6):585. doi:10.3390/brainsci15060585
BibTeX
@article{Ruchika2025,
author = {Ruchika, Fnu and Suvarnapathaki, Sanika and Serrano-Farias, Antolin and Bettegowda, Chetan and Rincon-Torroella, Jordina},
title = {GLUT1 as a Potential Therapeutic Target in Glioblastoma},
journal = {Brain Sciences},
year = {2025},
volume = {15},
number = {6},
pages = {585},
doi = {10.3390/brainsci15060585}
}
EUVIMED